Skip to main content
. 2020 Jun 12;10(6):1152. doi: 10.3390/nano10061152

Figure 7.

Figure 7

Figure 7

Pharmacological evaluation of the anti-leishmanial activities of the polymeric nanoparticles where different concentrations of nanoformulations were utilized: (a) inhibition of L. tropica KWH23 amastigotes at various concentrations and (b) inhibition of L. donovani amastigotes at various concentrations. Results are presented as mean ± SD of four experiments and were analyzed by paired t test and with a significance threshold denoted by p values set at * = p < 0.05 and ** = p <0.01.